September 25, 2018

Verastem Oncology Receives FDA Approval of COPIKTRA™ (duvelisib) Capsules

Treatment for adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after at least two prior therapies